Candriam S.C.A. Bio Rad Laboratories, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

A detailed history of Candriam S.C.A. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 31,527 shares of BIO stock, worth $10.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

31,527

Previous 23,374 34.88%

Holding current value

$10.5 Million

Previous $6.38 Million 65.25%

% of portfolio

0.06%

Previous 0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$263.97 - $344.64 $2.15 Million - $2.81 Million	8,153 Added 34.88%	31,527 $10.5 Million
Q2 2024 Aug 05, 2024	SELL	$268.26 - $339.48 $9.73 Million - $12.3 Million	-36,284 Reduced 60.82%	23,374 $6.38 Million
Q1 2024 May 03, 2024	SELL	$304.11 - $351.99 $12.1 Million - $14 Million	-39,666 Reduced 39.94%	59,658 $20.6 Million
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $7.06 Million - $9.56 Million	26,202 Added 35.83%	99,324 $32.1 Million
Q3 2023 Nov 13, 2023	SELL	$350.25 - $422.63 $6.61 Million - $7.97 Million	-18,869 Reduced 20.51%	73,122 $26.2 Million
Q2 2023 Aug 08, 2023	BUY	$359.49 - $486.4 $2.85 Million - $3.85 Million	7,916 Added 9.42%	91,991 $34.9 Million
Q1 2023 May 12, 2023	SELL	$418.69 - $503.0 $1.01 Million - $1.21 Million	-2,403 Reduced 2.78%	84,075 $40.3 Million
Q4 2022 Feb 13, 2023	SELL	$351.71 - $456.01 $3.22 Million - $4.18 Million	-9,157 Reduced 9.57%	86,478 $36.4 Million
Q3 2022 Nov 10, 2022	BUY	$412.59 - $563.26 $10.5 Million - $14.3 Million	25,352 Added 36.07%	95,635 $39.9 Million
Q2 2022 Aug 03, 2022	SELL	$463.67 - $597.16 $188,713 - $243,044	-407 Reduced 0.58%	70,283 $34.8 Million
Q1 2022 May 13, 2022	BUY	$524.57 - $735.42 $6.11 Million - $8.57 Million	11,652 Added 19.74%	70,690 $39.8 Million
Q4 2021 Feb 10, 2022	BUY	$708.84 - $794.68 $10.1 Million - $11.3 Million	14,195 Added 31.65%	59,038 $44.6 Million
Q3 2021 Nov 09, 2021	SELL	$657.71 - $825.77 $8.17 Million - $10.3 Million	-12,415 Reduced 21.68%	44,843 $33.4 Million
Q2 2021 Jul 20, 2021	SELL	$576.64 - $649.04 $42.4 Million - $47.7 Million	-73,514 Reduced 56.22%	57,258 $36.9 Million
Q1 2021 Apr 29, 2021	SELL	$547.01 - $662.35 $1,641 - $1,987	-3 Reduced -0.0%	130,772 $73.2 Million
Q4 2020 Jan 22, 2021	BUY	$510.68 - $643.45 $3.84 Million - $4.84 Million	7,523 Added 6.1%	130,775 $76.2 Million
Q3 2020 Oct 19, 2020	BUY	$454.43 - $535.6 $9.14 Million - $10.8 Million	20,107 Added 19.49%	123,252 $63.5 Million
Q2 2020 Jul 23, 2020	BUY	$334.87 - $493.06 $7.92 Million - $11.7 Million	23,644 Added 29.74%	103,145 $46.6 Million
Q1 2020 May 26, 2020	BUY	$320.01 - $409.07 $2,240 - $2,863	7 Added 0.01%	79,501 $28.8 Million
Q4 2019 Jan 21, 2020	BUY	$319.73 - $374.2 $3.53 Million - $4.13 Million	11,044 Added 16.13%	79,494 $29,000
Q3 2019 Oct 21, 2019	BUY	$304.55 - $345.24 $7.21 Million - $8.17 Million	23,660 Added 52.82%	68,450 $23,000
Q2 2019 Aug 01, 2019	BUY	$286.93 - $312.59 $430,395 - $468,884	1,500 Added 3.47%	44,790 $13.9 Million
Q4 2018 Feb 14, 2019	BUY	$220.1 - $309.0 $1.55 Million - $2.18 Million	7,040 Added 19.42%	43,290 $10.1 Million
Q3 2018 Nov 07, 2018	BUY	$289.28 - $326.15 $4.59 Million - $5.17 Million	15,850 Added 77.7%	36,250 $11.3 Million
Q2 2018 Aug 14, 2018	BUY	$244.1 - $303.88 $707,890 - $881,252	2,900 Added 16.57%	20,400 $5.89 Million
Q1 2018 May 09, 2018	BUY	$233.97 - $274.11 $2.11 Million - $2.47 Million	9,000 Added 105.88%	17,500 $4.38 Million
Q4 2017 Feb 07, 2018	BUY	$216.94 - $271.3 $1.84 Million - $2.31 Million	8,500	8,500 $2.03 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.19B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account